Generic Name and Formulations:
Cyclopentolate HCl 0.5%, 1%, 2%; oph soln; contains benzalkonium chloride.
Alcon Laboratories, Inc.
Indications for CYCLOGYL:
To produce mydriasis and cycloplegia.
Instill 1 or 2 drops of 0.5%, 1%, or 2% in the eye; may repeat in 5–10 minutes if necessary. Apply digital pressure to lacrimal sac for 2–3 minutes after instillation to reduce systemic absorption.
Small infants: instill 1 drop of 0.5% in the eye; apply pressure over nasolacrimal sac for 2–3 minutes, observe closely for 30 minutes. Children: instill 1 or 2 drops of 0.5%, 1%, or 2% in the eye; may repeat 5–10 minutes later with 0.5% or 1% solution if necessary; apply digital pressure to lacrimal sac for 2–3 minutes after instillation to reduce systemic absorption.
Untreated narrow-angle glaucoma or when untreated anatomically narrow angles are present.
Down's syndrome. Angle-closure glaucoma. Feeding intolerance in infants; withhold feeding for 4 hours after examination. Pregnancy (Cat.C). Nursing mothers.
May interfere with antihypertensive action of carbachol, pilocarpine, ophthalmic cholinesterase inhibitors.
Ocular effects (eg, increased intraocular pressure, burning, photophobia, blurred vision, irritation, hyperemia, conjunctivitis, blepharoconjunctivitis, punctate keratitis, synechiae); CNS disturbances (esp. in children).
Soln 0.5%—15mL; 1%, 2%—2mL, 5mL, 15mL
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Adjunctive Therapies for Bipolar Disorder Show Promise, Need More Evidence
- Predicting Treatment-Emergent Mania to Tailor Pharmacotherapy in Bipolar Disorder
- Abnormalities of Cortical Thickness in Bipolar Disorder With Auditory Hallucinations
- Prevalence of ADHD Relatively Stable Over Time Despite Increase in Diagnoses
- Cognitive Impairment May Predict Persistent Psychosis in Ketamine Users
- The Way to the Head May Be Through the Gut: Probiotics for Depression
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Evidence of Methylphenidate Abuse: Characterizing Patterns of Use in Pediatric and Adult Populations
- Intranasal Oxytocin Reduces Negative Effects, Improves Cognitive Function in Schizophrenia
- Most Patients Comfortable With Clinicians Asking About Sexual Orientation
- Peer-to-Peer Depression Awareness Program May Be Beneficial
- Examining Rates of Long-term Opioid Use in Youth With Psychiatric Disorders